Global Blood Plasma Fractionation Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Blood Plasma Fractionation market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Blood Plasma Fractionation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Blood Plasma Fractionation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Blood Plasma Fractionation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.

The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Blood Plasma Fractionation Segment by Company

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Blood Plasma Fractionation Segment by Type

Immune Globulin
Coagulation Factor
Albumin
Others

Blood Plasma Fractionation Segment by Application

Hospital
Retail Pharmacy
Others

Blood Plasma Fractionation Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Blood Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Blood Plasma Fractionation Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Blood Plasma Fractionation Sales Estimates and Forecasts (2020-2031)
1.3 Blood Plasma Fractionation Market by Type
1.3.1 Immune Globulin
1.3.2 Coagulation Factor
1.3.3 Albumin
1.3.4 Others
1.4 Global Blood Plasma Fractionation Market Size by Type
1.4.1 Global Blood Plasma Fractionation Market Size Overview by Type (2020-2031)
1.4.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2020-2025)
1.4.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2020-2025)
1.5.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2020-2025)
1.5.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Blood Plasma Fractionation Industry Trends
2.2 Blood Plasma Fractionation Industry Drivers
2.3 Blood Plasma Fractionation Industry Opportunities and Challenges
2.4 Blood Plasma Fractionation Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Blood Plasma Fractionation Revenue (2020-2025)
3.2 Global Top Players by Blood Plasma Fractionation Sales (2020-2025)
3.3 Global Top Players by Blood Plasma Fractionation Price (2020-2025)
3.4 Global Blood Plasma Fractionation Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Blood Plasma Fractionation Major Company Production Sites & Headquarters
3.6 Global Blood Plasma Fractionation Company, Product Type & Application
3.7 Global Blood Plasma Fractionation Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Blood Plasma Fractionation Market CR5 and HHI
3.8.2 Global Top 5 and 10 Blood Plasma Fractionation Players Market Share by Revenue in 2024
3.8.3 2023 Blood Plasma Fractionation Tier 1, Tier 2, and Tier 3
4 Blood Plasma Fractionation Regional Status and Outlook
4.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Blood Plasma Fractionation Historic Market Size by Region
4.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2020-2025)
4.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2020-2025)
4.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Blood Plasma Fractionation Forecasted Market Size by Region
4.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2026-2031)
4.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2026-2031)
4.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Blood Plasma Fractionation by Application
5.1 Blood Plasma Fractionation Market by Application
5.1.1 Hospital
5.1.2 Retail Pharmacy
5.1.3 Others
5.2 Global Blood Plasma Fractionation Market Size by Application
5.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2020-2031)
5.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2020-2025)
5.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Blood Plasma Fractionation Sales Breakdown by Application (2020-2025)
5.3.2 Europe Blood Plasma Fractionation Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Application (2020-2025)
5.3.4 South America Blood Plasma Fractionation Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Takeda
6.1.1 Takeda Comapny Information
6.1.2 Takeda Business Overview
6.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Blood Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments
6.2 CSL
6.2.1 CSL Comapny Information
6.2.2 CSL Business Overview
6.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Blood Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Blood Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 LFB Group
6.6.1 LFB Group Comapny Information
6.6.2 LFB Group Business Overview
6.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments
6.7 Biotest
6.7.1 Biotest Comapny Information
6.7.2 Biotest Business Overview
6.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biotest Blood Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments
6.8 BPL
6.8.1 BPL Comapny Information
6.8.2 BPL Business Overview
6.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPL Blood Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments
6.9 RAAS
6.9.1 RAAS Comapny Information
6.9.2 RAAS Business Overview
6.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.9.4 RAAS Blood Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments
6.10 CBPO
6.10.1 CBPO Comapny Information
6.10.2 CBPO Business Overview
6.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Blood Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments
6.11 Hualan Bio
6.11.1 Hualan Bio Comapny Information
6.11.2 Hualan Bio Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments
6.12 Tiantan Bio
6.12.1 Tiantan Bio Comapny Information
6.12.2 Tiantan Bio Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Comapny Information
6.13.2 Shuanglin Bio Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments
6.14 Boya Bio
6.14.1 Boya Bio Comapny Information
6.14.2 Boya Bio Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Comapny Information
6.15.2 Yuanda Shuyang Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments
6.16 Weiguang Bio
6.16.1 Weiguang Bio Comapny Information
6.16.2 Weiguang Bio Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments
6.17 Nanyue Bio
6.17.1 Nanyue Bio Comapny Information
6.17.2 Nanyue Bio Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments
6.18 KM Biologics
6.18.1 KM Biologics Comapny Information
6.18.2 KM Biologics Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2020-2025)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments
7 North America by Country
7.1 North America Blood Plasma Fractionation Sales by Country
7.1.1 North America Blood Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Blood Plasma Fractionation Sales by Country (2020-2025)
7.1.3 North America Blood Plasma Fractionation Sales Forecast by Country (2026-2031)
7.2 North America Blood Plasma Fractionation Market Size by Country
7.2.1 North America Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Blood Plasma Fractionation Market Size by Country (2020-2025)
7.2.3 North America Blood Plasma Fractionation Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Blood Plasma Fractionation Sales by Country
8.1.1 Europe Blood Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Blood Plasma Fractionation Sales by Country (2020-2025)
8.1.3 Europe Blood Plasma Fractionation Sales Forecast by Country (2026-2031)
8.2 Europe Blood Plasma Fractionation Market Size by Country
8.2.1 Europe Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Blood Plasma Fractionation Market Size by Country (2020-2025)
8.2.3 Europe Blood Plasma Fractionation Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Blood Plasma Fractionation Sales by Country
9.1.1 Asia-Pacific Blood Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Blood Plasma Fractionation Sales by Country (2020-2025)
9.1.3 Asia-Pacific Blood Plasma Fractionation Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Blood Plasma Fractionation Market Size by Country
9.2.1 Asia-Pacific Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Blood Plasma Fractionation Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Blood Plasma Fractionation Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Blood Plasma Fractionation Sales by Country
10.1.1 South America Blood Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Blood Plasma Fractionation Sales by Country (2020-2025)
10.1.3 South America Blood Plasma Fractionation Sales Forecast by Country (2026-2031)
10.2 South America Blood Plasma Fractionation Market Size by Country
10.2.1 South America Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Blood Plasma Fractionation Market Size by Country (2020-2025)
10.2.3 South America Blood Plasma Fractionation Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Blood Plasma Fractionation Sales by Country
11.1.1 Middle East and Africa Blood Plasma Fractionation Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2020-2025)
11.1.3 Middle East and Africa Blood Plasma Fractionation Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Blood Plasma Fractionation Market Size by Country
11.2.1 Middle East and Africa Blood Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Blood Plasma Fractionation Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Blood Plasma Fractionation Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Blood Plasma Fractionation Value Chain Analysis
12.1.1 Blood Plasma Fractionation Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Blood Plasma Fractionation Production Mode & Process
12.2 Blood Plasma Fractionation Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Blood Plasma Fractionation Distributors
12.2.3 Blood Plasma Fractionation Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings